Diagnostic score of malignancy risk in the people having a node in thyroid gland (Petrov Thyroid Cancer Score, PTCS)
A. M. Belyaev,
L. M. Berstein,
D. A. Vasil’ev,
E. V. Kostromina,
L. A. Krasil’nikova,
P. I. Krzhivitskiy,
A. A. Mikhet’ko,
A. V. Mishchenko,
S. N. Novikov,
Z. A. Radzhabova,
D. A. Sinyachkina,
E. V. Tsyrlina https://doi.org/10.17650/2222-1468-2018-8-1-17-23
Abstract
A method for assessing the likelihood of finding a differentiated thyroid cancer based on the use of the Petrov Thyroid Cancer Score (PTCS) is proposed. The individual components of the score are divided into 4 groups in terms of their diagnostic significance. PTCS reflects the opinions of specialists working in the different areas of oncology and needs further approbation based on retro- and prospective studies
About the Authors
A. M. Belyaev
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
L. M. Berstein
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
D. A. Vasil’ev
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
E. V. Kostromina
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
L. A. Krasil’nikova
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
P. I. Krzhivitskiy
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
A. A. Mikhet’ko
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
A. V. Mishchenko
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
S. N. Novikov
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Z. A. Radzhabova
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
D. A. Sinyachkina
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
E. V. Tsyrlina
N.N. Petrov National Medical Research Center of Oncology, Ministry of Health of Russia.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
Russian Federation
68 Leningradskaya St., Pesochnyy Settlement, Saint Petersburg 197758.
References
1. Заридзе Д.Г. Проблема гипердиагностики в онкологии. В сб.: III Всероссийская конференция по фундаментальной онкологии. М.: НМИЦ онкологии им. Н.Н. Блохина, 2017. [Zaridze D.G. Problem of overdiagnosis in oncology. In: III Russian conference of Fundamental Oncology. Moscow: N.N. Blo khin NMRCO, 2017. (In Russ.)].
2. Hoang J.K., Nguyen X.V., Davies L. Overdiagnosis of thyroid cancer: answers to five key questions. Acad Radiol 2015;22(8):1024–9. DOI: 10.1016/j.acra.2015.01.019.
3. Park S.H., Lee B., Lee S. et al. A qualitative study of women's views on overdiagnosis and screening for thyroid cancer in Korea. BMC Cancer 2015;15:858. DOI: 10.1186/s12885-015-1877-6.
4. Sanabria A., Kowalski L.P., Shah J.P. et al. Growing incidence of thyroid carcinoma in recent years: factors underlying overdiagnosis. Head Neck 2018;40(4):855–66. DOI: 10.1002/hed.25029.
5. Tessler F.N., Middleton W.D., Grant E.G. et al. ACR Thyroid Imaging, Reporting and Data System (TI-RADS): White Paper of the ACR TI-RADS Committee. J Am Coll Radiol 2017;14(5):587–95. DOI: 10.1016/j.jacr.2017.01.046.
6. Cibas E.S., Ali S.Z. The 2017 Bethesda System for Reporting Thyroid Cytopathology. Thyroid 2017;27(11):1341–6. DOI: 10.1089/thy.2017.0500.
7. Yang B.R., Kim E.K., Moon H.J. et al. Qualitative and semiquantitative elastography for the diagnosis of intermediate suspicious thyroid nodules based on the American 2015 Thyroid Association Guidelines. J Ultrasound Med 2017; Oct 16. DOI: 10.1002/jum.14449.
8. Yamashita S., Suzuki S., Suzuki S. et al. Lessons from Fukushima: latest findings of thyroid cancer after the Fukushima nuclear power plant accident. Thyroid 2018;28(1): 11–22.; DOI: 10.1089/thy.2017.0283.
9. Russ G., Leboulleux S., Leenhardt L., Hegedüs L. Thyroid incidentalomas: epidemiology, risk stratification with ultrasound and workup. Eur Thyroid J 2014;3(3):154–63. DOI: 10.1159/000365289.
10. Синячкина Д.А. Оптимизация диагностических мероприятий и лечебной тактики при распространенном раке щитовидной железы: автореф. дис. … канд. мед. наук. СПб., 2017. 21 с. [Sinyachkina D.A. Optimization of diagnostic procedures and treatment strategy in advanced thyroid cancer: author's abstract of dis. … cand. of med. sciences. Saint Petersburg, 2017. 21 p. (In Russ.)].
11. Zheng J., Li C., Lu W. et al. Quantitative assessment of preoperative serum thyrotropin level and thyroid cancer. Oncotarget 2016;7(23):34918–29. DOI: 10.18632/ oncotarget.9201.
12. Nixon I.J., Suárez C., Simo R. et al. The impact of family history on non-medullary thyroid cancer. Eur J Surg Oncol 2016;42(10):1455–63. DOI: 10.1016/j. ejso.2016.08.006.
13. Zimmermann M.B., Galetti V. Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies. Thyroid Res 2015;8:8. DOI: 10.1186/s13044-015-0020-8.
14. Malaguarnera R., Vella V., Nicolosi M.L., Belfiore A. Insulin Resistance: Any Role in the Changing Epidemiology of Thyroid Cancer? Front Endocrinol (Lausanne) 2017;8:314. DOI: 10.3389/ fendo.2017.00314.
15. Poller D.N., Glaysher S. Molecular pathology and thyroid FNA. Cytopathology 2017;28(6):475–81. DOI: 10.1111/ cyt.12492.
16. Baloch Z.W., Fleisher S., LiVolsi V.A., Gupta P.K. Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol 2002;26(1):41–4.
17. Singaporewalla R.M., Hwee J., Lang T.U., Desai V. Clinico-pathological correlation of thyroid nodule ultrasound and cytology using the TIRADS and Bethesda сlassifications. World J Surg 2017;41(7): 1807–11. DOI: 10.1007/s00268-0173919-5.
18. Борсуков А.В., Морозова Т.Г., Кова- лев А.В. и др. Стандартизированная методика компрессионной соноэластографии щитовидной железы. Эндокринная хирургия 2014;(1):55–61. [Borsukov A.V., Morozova T.G., Kovalev A.V. et al. A standardized method for compression sonoelastography of thyroid gland. Endokrinnaya khirurgiya = Endocrine Surgery 2014;(1):55–61. (In Russ.)]. DOI: 10.14341/serg2014(1)55–61.
19. Evans C., Tennant S., Perros P. Thyroglobulin in differentiated thyroid cancer. Clin Chim Acta 2015;444:310–7. DOI: 10.1016/j.cca.2014.10.035.
20. Treglia G., Muoio B., Giovanella L., Salvatori M. The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview. Eur Arch Otorhinolaryngol 2013;270(6):1783–7. DOI: 10.1007/s00405-012-2205-2.
21. Samsonov R., Burdakov V., Shtam T. et al. Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer. Tumour Biol 2016;37(9):12011–21. DOI: 10.1007/ s13277-016-5065-3.
Review
For citations:
Belyaev A.M., Berstein L.M., Vasil’ev D.A., Kostromina E.V., Krasil’nikova L.A., Krzhivitskiy P.I., Mikhet’ko A.A., Mishchenko A.V., Novikov S.N., Radzhabova Z.A., Sinyachkina D.A., Tsyrlina E.V. Diagnostic score of malignancy risk in the people having a node in thyroid gland (Petrov Thyroid Cancer Score, PTCS). Head and Neck Tumors (HNT). 2018;8(1):17-23. (In Russ.) https://doi.org/10.17650/2222-1468-2018-8-1-17-23
Views:
933
Email this article 